Dental Safety Profile of High-Dose Radioiodine Therapy

• Status: Completed
• Trial end date: 2006-09-01
• Target enrollment: 0
• Participant gender: All

Summary

We aim to assess the incidence of oral and dental adverse events after high-dose radioiodine therapy for differentiated thyroid cancer.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Basel, Switzerland

Criteria

Inclusion Criteria:

• histologically confirmed differentiated thyroid cancer

• status after total thyroidectomy

• status after subsequent high-dose radioiodine treatment

• regular follow-up by a board-certified dentist

• a minimum follow-up of 1 year after radioiodine therapy.

Exclusion Criteria:

• anaplastic thyroid cancer